Joshua E. Meyer

3.3k total citations · 1 hit paper
113 papers, 2.2k citations indexed

About

Joshua E. Meyer is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Joshua E. Meyer has authored 113 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 59 papers in Oncology, 45 papers in Pulmonary and Respiratory Medicine and 44 papers in Surgery. Recurrent topics in Joshua E. Meyer's work include Advanced Radiotherapy Techniques (22 papers), Pancreatic and Hepatic Oncology Research (18 papers) and Esophageal Cancer Research and Treatment (17 papers). Joshua E. Meyer is often cited by papers focused on Advanced Radiotherapy Techniques (22 papers), Pancreatic and Hepatic Oncology Research (18 papers) and Esophageal Cancer Research and Treatment (17 papers). Joshua E. Meyer collaborates with scholars based in United States, Russia and Canada. Joshua E. Meyer's co-authors include Nicholas G. Zaorsky, Brian L. Egleston, Eric M. Horwitz, Susan G. Fisher, T.M. Churilla, John A. Ridge, David L. Sherr, Nestor F. Esnaola, Crystal S. Denlinger and Steven J. Cohen and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and JNCI Journal of the National Cancer Institute.

In The Last Decade

Joshua E. Meyer

106 papers receiving 2.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Causes of death among cancer patients

2016 450 citations Nicholas G. Zaorsky, T.M. Churilla et al. Annals of Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Joshua E. Meyer United States	21	1.1k	756	640	431	307	113	2.2k
Michael Ghadimi Germany	26	1.7k 1.5×	1.1k 1.5×	667 1.0×	188 0.4×	220 0.7×	179	2.7k
Christiane Matuschek Germany	23	600 0.5×	390 0.5×	441 0.7×	275 0.6×	244 0.8×	110	1.8k
A. Aupérin France	29	1.2k 1.1×	839 1.1×	1.3k 2.0×	235 0.5×	303 1.0×	77	3.2k
Gianmauro Numico Italy	28	1.1k 1.0×	531 0.7×	776 1.2×	172 0.4×	238 0.8×	115	2.6k
Jean‐Pierre Lotz France	26	1.6k 1.4×	698 0.9×	699 1.1×	345 0.8×	255 0.8×	119	2.8k
Daniela Musio Italy	26	941 0.8×	585 0.8×	685 1.1×	121 0.3×	569 1.9×	129	2.1k
Michael A. Savin United States	26	1.8k 1.6×	430 0.6×	716 1.1×	166 0.4×	285 0.9×	61	3.0k
Tawee Tanvetyanon United States	32	1.7k 1.5×	724 1.0×	1.3k 2.1×	168 0.4×	288 0.9×	135	3.3k
Sadhana Kannan India	24	512 0.5×	509 0.7×	780 1.2×	148 0.3×	450 1.5×	145	2.6k
Clare Peckitt United Kingdom	31	1.7k 1.5×	1.1k 1.4×	1.8k 2.8×	778 1.8×	437 1.4×	102	3.9k

Countries citing papers authored by Joshua E. Meyer

Since Specialization

Citations

This map shows the geographic impact of Joshua E. Meyer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joshua E. Meyer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joshua E. Meyer more than expected).

Fields of papers citing papers by Joshua E. Meyer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joshua E. Meyer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joshua E. Meyer. The network helps show where Joshua E. Meyer may publish in the future.

Co-authorship network of co-authors of Joshua E. Meyer

This figure shows the co-authorship network connecting the top 25 collaborators of Joshua E. Meyer. A scholar is included among the top collaborators of Joshua E. Meyer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joshua E. Meyer. Joshua E. Meyer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lukez, Alexander, Zhang Li, Eric M. Horwitz, et al.. (2025). Computed Tomography-Guided Online Adaptive Stereotactic Body Radiation Therapy for Liver Tumors: A Retrospective Study. International Journal of Radiation Oncology*Biology*Physics. 122(3). 659–667. 1 indexed citations

Jain, Rishi, Chethan Ramamurthy, Daohai Yu, et al.. (2023). Understanding the Challenges Faced by Esophageal and Gastroesophageal Junction Cancer Survivors. Journal of Patient Experience. 10. 672688921–672688921. 2 indexed citations

Serebriiskii, Ilya G., Samuel Litwin, Justin Y. Newberg, et al.. (2023). Source, co-occurrence, and prognostic value of PTEN mutations or loss in colorectal cancer. npj Genomic Medicine. 8(1). 40–40. 3 indexed citations

Serebriiskii, Ilya G., Rossella Tricarico, Émmanuelle Nicolas, et al.. (2022). Comprehensive characterization of PTEN mutational profile in a series of 34,129 colorectal cancers. Nature Communications. 13(1). 1618–1618. 31 indexed citations

Hall, Michael J., et al.. (2022). Therapeutic implications of germline vulnerabilities in DNA repair for precision oncology. Cancer Treatment Reviews. 104. 102337–102337. 10 indexed citations

Sharma, Navesh, S. Cheenu Kappadath, Michael D. Chuong, et al.. (2022). The American Brachytherapy Society consensus statement for permanent implant brachytherapy using Yttrium-90 microsphere radioembolization for liver tumors. Brachytherapy. 21(5). 569–591. 7 indexed citations

Kumar, Sameera, Xiaoliang Wang, Gregory S. Calip, et al.. (2022). Real-world Use of Radiation for Newly Diagnosed Brain Metastases in Patients With ALK-positive Lung Cancer Receiving First-line ALK Inhibitor. International Journal of Radiation Oncology*Biology*Physics. 114(4). 627–634. 1 indexed citations

VanderWalde, Noam A., Jennifer Moughan, Stuart M. Lichtman, et al.. (2021). The association of age with acute toxicities in NRG oncology combined modality lower GI cancer trials. Journal of Geriatric Oncology. 13(3). 294–301. 5 indexed citations

Lieu, Christopher H., Erica A. Golemis, Ilya G. Serebriiskii, et al.. (2019). Comprehensive Genomic Landscapes in Early and Later Onset Colorectal Cancer. Clinical Cancer Research. 25(19). 5852–5858. 135 indexed citations

10.

Serebriiskii, Ilya G., Caitlin Connelly, Garrett M. Frampton, et al.. (2019). Comprehensive characterization of RAS mutations in colon and rectal cancers in old and young patients. Nature Communications. 10(1). 3722–3722. 149 indexed citations

11.

Meyer, Joshua E., Mark J. Rivard, R Price, et al.. (2018). Initial Clinical Experience with Uni-Directional LDR Brachytherapy in the Treatment of Retroperitoneal Sarcoma. International Journal of Radiation Oncology*Biology*Physics. 102(3). e256–e256. 2 indexed citations

12.

Esnaola, Nestor F., Crystal S. Denlinger, Andreas Karachristos, et al.. (2018). Concurrent chemoradiation for resected gall bladder cancers and cholangiocarcinomas. Journal of Gastrointestinal Oncology. 9(4). 762–768. 5 indexed citations

13.

Lee, Charles T., Yanqun Dong, Tianyu Li, et al.. (2017). Local Control and Toxicity of External Beam Reirradiation With a Pulsed Low-dose-rate Technique. International Journal of Radiation Oncology*Biology*Physics. 100(4). 959–964. 9 indexed citations

14.

Zaorsky, Nicholas G., T.M. Churilla, Brian L. Egleston, et al.. (2016). Causes of death among cancer patients. Annals of Oncology. 28(2). 400–407. 450 indexed citations breakdown →

15.

Zaorsky, Nicholas G., Stefan K. Barta, Nestor F. Esnaola, et al.. (2016). Splenic irradiation for splenomegaly: A systematic review. Cancer Treatment Reviews. 53. 47–52. 33 indexed citations

16.

Shaikh, Talha, Thomas M. Churilla, Colin T. Murphy, et al.. (2016). Absence of Pathological Proof of Cancer Associated with Improved Outcomes in Early-Stage Lung Cancer. Journal of Thoracic Oncology. 11(7). 1112–1120. 14 indexed citations

17.

Wang, Lora S., Talha Shaikh, Elizabeth A. Handorf, et al.. (2015). Dose escalation with a vessel boost in pancreatic adenocarcinoma treated with neoadjuvant chemoradiation. Practical Radiation Oncology. 5(5). e457–e463. 7 indexed citations

18.

Zaorsky, Nicholas G., Talha Shaikh, Elizabeth A. Handorf, et al.. (2015). What Are Medical Students in the United States Learning About Radiation Oncology? Results of a Multi-Institutional Survey. International Journal of Radiation Oncology*Biology*Physics. 94(2). 235–242. 57 indexed citations

19.

Hoffman, John P., et al.. (2013). Impact of preoperative therapy on patterns of recurrence in pancreatic cancer. HPB. 16(1). 34–39. 28 indexed citations

20.

Stessin, A., Joshua E. Meyer, & David L. Sherr. (2007). Pre-Operative Radiation is Associated With Improved Survival in Patients With Resectable Pancreatic Cancer: Analysis of Data From the Surveillance, Epidemiology, and End Results (SEER) Registry. International Journal of Radiation Oncology*Biology*Physics. 69(3). S272–S272.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact